REG - Iconic Labs PLC - Retraction of claims

Iconic LabsAnnouncement

23/08/2022 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220823:nRSW9734Wa&default-theme=true

RNS Number : 9734W  Iconic Labs PLC  23 August 2022

Iconic Labs PLC

Retraction of claims made against David Sefton and the former directors of
Iconic Labs Plc

The directors and Joint Administrators of Iconic Labs Plc ("the Company") wish
to clarify matters in respect of the allegations of wrongdoing previously made
against David Sefton, the former directors and several other entities and
persons connected with them.

These claims were originally made on the basis of factual assumptions which
the directors believed to be true on the date that the claims were originally
made. The  board notes that no legal proceedings were ever commenced, and
matters had not proceeded beyond exchanges of letters among lawyers.  As part
of these exchanges documents and other evidence were provided and discussed.
As a result the board has concluded that the factual assumptions underlying
the originally asserted claims were not correct.  That this situation arose
was at least in part due to the incomplete and unsatisfactory state of the
company records when they were originally handed over to the current
directors.

As an example, the most important part of the allegations, and the only part
giving rise to any material claim in damages, was that an allegation that a
change of control clause entitling Greencastle to terminate the management
services contract with the Company in respect of JOE Media had been inserted
into that agreement only in December 2020 once it became apparent that the
former directors might be left with no alternative than to resign.  From
this, an assumption had been made that the contract was being amended only for
the purpose of depriving the Company of the benefit of management fees going
forward. This was not correct.  The change of control clause was included in
the management services contract when it was originally entered into, was a
normal and usual commercial clause in such contracts and was present in
identical form in all other management services contracts that Greencastle had
entered into.

Further investigations by forensic accountants and lawyers engaged by the
directors also failed to uncover any evidence of any wrongdoing or
inappropriate behaviour by any of David Sefton, the former directors or any
entity connected to them.

In these circumstances, it would be inappropriate for the Company to continue
to maintain that there was any wrongdoing by any of David Sefton, the former
directors or any entity connected to them or to continue to assert that there
is any prospect of a legal claim being established against any of them.  In
accordance with their fiduciary duties, the board has no reservations about
withdrawing the alleged claims in full.

The directors also note that the £1,000,000 loan note from Greencastle was
repaid in its entirety by virtue of Greencastle's valid exercise of a
contractual right of set-off.

The directors have offered an apology to, among others, David Sefton and the
former directors for the claims having been made, and in response David Sefton
noted that he not only accepted the apology but recognised that the directors
had been properly following their directors' duties to investigate all
relevant matters relating to the Company and agreed with them that it can be
difficult for an incoming board, often with difficulties in accessing
documentary records, to form a complete picture of past events.  Both David
Sefton and the board now consider the matter to be closed.

 

WA Batty

For Iconic Labs PLC

Joint Administrator 22 August 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEXLFLLVLZBBX